Search

Your search keyword '"Malta, Tathiane M."' showing total 211 results

Search Constraints

Start Over You searched for: Author "Malta, Tathiane M." Remove constraint Author: "Malta, Tathiane M."
211 results on '"Malta, Tathiane M."'

Search Results

1. Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas

2. Glioma progression is shaped by genetic evolution and microenvironment interactions

3. Predicting master transcription factors from pan-cancer expression data

6. Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas

7. Advances in Central Nervous System Tumor Classification

8. Longitudinal molecular trajectories of diffuse glioma in adults

9. The Immune Landscape of Cancer

10. The Immune Landscape of Cancer

11. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

12. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

13. Table S1 from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

14. Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

15. Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

16. Data from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

17. Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

18. Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas

19. A global metagenomic map of urban microbiomes and antimicrobial resistance

21. Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis

22. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

23. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

24. The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

25. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

26. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

27. The Immune Landscape of Cancer

28. A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence

29. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

30. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

31. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

34. Data from Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

35. Supplementary Figures and legends from Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

36. Supplementary Table 2 from Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

37. Supplementary Table 3 from Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

38. Supplementary Materials and Methods-PJA1-Cancer research from Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

39. Supplementary Table 4 from Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

40. Supplementary Table 1 from Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling

41. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition

43. Molecular landscape of IDH‐wild type, pTERT‐wild type adult glioblastomas

44. Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors

45. A global metagenomic map of urban microbiomes and antimicrobial resistance

46. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features

47. A serum-based DNA methylation assay provides accurate detection of glioma

50. Detection of Circulating Tumor-specific DNA Methylation Markers in the Blood of Patients with Pituitary Tumors

Catalog

Books, media, physical & digital resources